PARNAX LAB LTD. Financial Ratios
PARNAXLAB · Healthcare · Current price ₹108.55
P/E ratio
10.6x
P/B ratio
1.6x
ROE
12.4%
ROCE
11.7%
Debt / Equity
0.95
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 10.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 11.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.95 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with PARNAX LAB LTD.'s latest numbers.
PARNAX LAB LTD. profitability
PARNAX LAB LTD. generates a return on equity of 12.4% and a return on capital employed of 11.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.95 and a P/E of 10.6x, PARNAX LAB LTD. is moderately leveraged. Our overall business-quality score for the company is 4.4 / 10.
Understand the ratios
More on PARNAX LAB LTD.
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.